Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold?
Yohei Sotomi(Kyoto University), Patrick W. Serruys(Erasmus MC), Pannipa Suwannasom(Amsterdam UMC Location University of Amsterdam), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Yosuke Miyazaki(Yamaguchi University), Michael J. Lipinski(Northwestern University), Robbert J. de Winter(Leiden University Medical Center), Taku Asano(Amsterdam UMC Location University of Amsterdam), Ron Waksman(Clinical Research Institute), Jan Tijssen, Carlos Collet(Onze Lieve Vrouwziekenhuis Hospital)
Cited by 5
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k